Small,dense LDL and high-sensitivity C-reactive protein (hs-CRP) in metabolic syndrome with type 2 diabetes mellitus

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 4, 2010, Pages 410-415

  Nakano, Saburo ^a   Kuboki, Koji ^a   Matsumoto, Tomoko ^a   Nishimura, Chiaki ^a   Yoshino, Gen ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dense LDL cholesterol; HDL cholesterol; Hs CRP; Metabolic syndrome; Small; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 77953520974     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.1891     Document Type: Article

References (27)

1. Definition and the diagnostic standard for metabolic syn-drome -Committee to Evaluate diagnostic Standard for Metabolic Syndrome. Nippon Naikagakkai Zasshi, 2005; 94: 794-789 (in Japanese).
2. Kuusisto J, Lempiainen P, Mykkanen L, Laakso M: Insu-lin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men. Diabetes Care, 2001; 24: 1629-1633.
3. Pyorala M, Miettinen H, Halonen P, Laakso M, Pyorala K: Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policeman Study. Arterioscler Thromb Vasc Biol, 2000; 20: 538-544.
4. Ford ES: The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis, 2004; 173: 309-314.
5. Turner R, Holman RRC, Millns H, Neil HA, Stratton IM, Manley DR: Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: UK Prospec-tive Diabetes Study (UKPDS 23). BMJ, 1998; 316: 823-828.
6. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and nondiabetic subjects with and with-out prior myocardial infarction. N Engl J Med, 1998; 339: 229-234.
7. Krauss RM, Burke DJ: Identification of multiple subclass of plasma low density lipoproteins in normal humans. J Lipid Res, 1982; 23: 97-104.
8. Hirano T, Ito Y, Saegusa H, Yoshino G: A novel and sim-ple method for quantification of small dense low-density lipoprotein. J Lipid Res, 2003; 44: 2193-2201.
9. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hen-nekens CH: Inflammation, aspirin, and risks of cardiovas-cular disease in apparently healthy men. N Engl J Med, 1997; 336: 973-979.
10. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation, 1998; 98: 731-733.
11. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH: Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol, 1997; 17: 1121-1127.
12. Carabro P, Willerson JT, Yeh ETH: Inflammatory cyto-kines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation, 2003; 108: 1930-1932.
13. Yasojima K, Schwab C, McGeer PL: Generation of C-reac-tive protein and compliment components in atheroscle-rotic plaques. Am J Pathol, 2001; 158: 1039-1051.
14. Carabro P, Chang DW, Willerson JT, Yeh ETH: Release of C-reactive protein in responce to inflammatory cyto-kines by human adipicytes: linking obesity to vasclular inflammation (research correspondence). J Am Coll Car-diol, 2005; 46: 1112-1113.
15. Ridker PM, Haughie P: Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. J Invest Med, 1998; 46: 391-395.
16. Ledue TB, Weiner DL, Sipe J, Poulin SE, Collins MF, Rifai N: Analytical evaluation of particle-enhanced immu-nonepherometric assays for C-reactiive protein, serum amyloid-A and mannose-binding protein in human seum. Clin Chem, 1997; 43: s240.
17. Reaven GM: Banting lecture 1988·Role of insulin resis-tance in human disease. Diabetes, 1988; 37: 1595-1607.
18. Kaplan NM: The deadly quartet·Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hyperten-sion. Arch Intern Med, 1989; 149: 1514-1520.
19. DeFronzo RA, Ferrannini E: Insulin resistance, A multi-faceted syndrome responsible for NIDDM, obesity, hyper-tension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care, 1991; 14: 173-194.
20. Matsuzawa Y, Funahashi T, Nakamura T: Molecular mech-anism of metabolic syndrome X: contribution of adipocy-tokines adipocyte-derived bioactive substances, Ann NY Acad Sci, 1999; 892: 146-154.
21. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S: contribu-tion of intra-abdominal fat accumulation. to the glucose and lipid metabolism in human obesity. Metabolism, 1987; 36: 54-59.
22. Hulthe J, Bokemark L, Wikstrand J, Fagerberg B: The Metabolic syndrome, LDL particle size, and atherosclero-sis: The atherosclerosis and insulin resistance (AIR) study. Arterioscler Thromb Vasc Biol, 2000; 20: 2140-2147.
23. Rajiman I, Kenall MJ, Cramb R, Holder RL, Salih M, Gambage MD: Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceri-demicmen. Atherosclerosis, 1996; 125: 231-242.
24. Yoshino G, Hirano T, Kazumi T: Atherogenic lipoproteins and diabetes melltus. J Diab Comp, 2002; 16: 29-34.
25. Nozue T, Michishita I, Ishibashi Y, Ito Y, Iwaki T, Mizu-guchi I, Miura M, Ito Y, Hirano T: Small dense low-den-sity lipoprotein cholesterol is a usueful marker of meta-bolic syndrome in patients with coronary artery disease. J Atheroscler Thromb, 2007; 14: 202-207.
26. Kaathiresan S, Otvos JD, Sullivan LM, Keyes MJ, Schae-fer EJ, Wilson PW, D'Agostino RB, Vasan RS, Robins SJ: Increased small low-density lipoprotein particle num-ber: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation, 2006; 113: 20-29.
27. Watson TD, Caslake MJ, Freeman DJ, Griffin BA, Hin-nie J, Packard CJ, Shepherd J: Determinants of LDL sub-fraction distribution and concentrations in young normo-lipidemic subjects. Arterioscler Thromb Vasc Biol, 1994; 14: 902-910.